IMBiologics transfers autoimmune disease drug tech to Huadong Pharma
South Korea's antibody-based biotech company IMBiologics announced on Friday that it signed a contract to transfer the technology of its autoimmune ...
HK inno.N to release K-CAB in MENA market
South Korean bio-health company HK inno.N announced on Tuesday that it signed a contract with Saudi Arabian local pharmaceutical company Tabuk Pharm...
Boryung, HK inno.N to co-market Kanarb, K-CAB
South Korea’s pharmaceutical companies Boryung Corp. and HK inno.N announced on Wednesday that they will start co-marketing for their respec...
HK inno.N reveals differentiated clinical results for K-CAB
South Korean bio-health company HK inno.N has been expanding its market by steadily announcing differentiated clinical results for its gastroesophag...
HK inno.N releases K-Cab in Singapore
South Korean bio-health company HK inno.N announced on Monday that it has released the new drug K-CAB for gastroesophageal reflux disease (GERD) in ...
HK inno.N releases new drug for GERD in Indonesia
South Korean bio-health company HK inno.N Corporation's new drug for gastroesophageal reflux disease (GERD) K-CAB has been officially launched in In...
Designer of 2018 Winter Olympic cauldron returns with solo golf cart
Personal space has become more important since the COVID-19 pandemic swept the world, and one South Korean-led industrial design company has develop...
CJ CheilJedang opens internal venture development space Inno Play
South Korea's food and bio giant CJ CheilJedang Corp. on Sunday said it opened Inno Play, an office space for commercializing innovative ideas and d...
HK inno.N's GERD drug K-CAB gets approval in Mexico
South Korea's biohealth company HK inno.N said on Tuesday that its gastroesophageal reflux disease (GERD) treatment K-CAB (active ingredient: tegopr...
S.Korea, Japan compete in gastroesophageal reflux drug market
South Korea is battling Japan again, this time on the global market to treat gastroesophageal reflux disease (GERD). South Korea's pharmaceutical pr...
HK inno.N to introduce biosimilars for bone disease treatment from Spain
South Korea's biohealth company HK inno.N said on Wednesday that it has signed an agreement with Spanish pharmaceutical company mAbxience SA to intr...
HK inno.N's K-CAB to get insurance benefits in China
South Korea’s 30th novel medicine K-CAB Tab (active ingredient: tegoprazan), a gastroesophageal reflux disease (GERD) treatment of HK inno.N, ...
HK inno.N gets approval to sell K-CAB in Singapore
South Korean biohealth company HK inno.N said on Wednesday that it has received an item approval for K-CAB, a new drug for gastroesophageal reflux d...
HK inno.N receives sales permit for ulcer treatment in China
HK inno.N is expediting its global expansion with its latest drug K-Cab designed to treat peptic ulcers.The South Korean pharmaceutical company an...
HK inno.N’s K-CAB a blockbuster drug with $843 million exports
South Korea’s HK inno.N Corp. has signed a 640 billion won ($540 million) contract to license out its technology for K-CAB, a gastroesophageal...
HK inno.N’s IPO attracts $25 bn from retail investors
HK inno.N Corp. (inno.N), a pharmaceuticals unit of Kolmar Korea, drew a massive $25 billion from retail investors for its listing thanks to its s...
HK inno.N’s IPO price set at top end with record demand for Kosdaq listing
HK inno.N Corp. (inno.N), a pharmaceuticals unit of South Korea's Kolmar Korea, set the initial public offering price at the top end of the proposed...
STIC to cash in on Aug IPOs following HYBE block sale
South Korea's private equity firm STIC Investments Inc. is tipped to be one of the main beneficiaries of upcoming initial public offerings in the co...
HK inno.N poised to bolster S.Korea's IPO lineup in H2
HK inno.N Corp., a pharmaceuticals unit of South Korea's Kolmar Korea, is set to go public in early August at a valuation of around 2 trillion won (...
HK inno.N plans 2021 IPO with $1.8 bn valuation
HK inno.N Corp. (inno.N), previously known as CJ Healthcare Co. and now a subsidiary of Kolmar Korea, has initiated the IPO process for listing with...
